Q&A: BIO CEO Michelle McMurry-Heath Outlines Diversity Goals

New BIOEquality Agenda Tackles Trial Participation, Access, Education

 
• By Mandy Jackson

Expanding on difficult conversations during the recent BIO Digital meeting, the group aims to take actions that will increase diversity and inclusion in health care, science and industry.

Designer Teamwork Brainstorming Planning Meeting Concept
The BIOEquality Agenda is focused on clinical trials, health care and the workforce • Source: Shutterstock

More from Clinical Trials

More from R&D